First Line Chemotherapy in Low Risk Gestational Trophoblastic Neoplasia

doi 10.1002/14651858.cd007102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

John Wiley & Sons, Ltd

Related search

Efficacy and Risk Factors Associated to Resistance to Single-Agent Chemotherapy in Low-Risk Gestational Trophoblastic Neoplasia

Open Journal of Obstetrics and Gynecology
2016English

The 16-Year Experience in Treating Low-Risk Gestational Trophoblastic Neoplasia Patients With Failed Primary Methotrexate Chemotherapy

Journal of Gynecologic Oncology
MedicineGynecologyOncologyObstetrics
2020English

Pulmonary Metastases Increase Chemotherapy Resistance and Recurrence of Gestational Trophoblastic Neoplasia

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2020English

A Case of Methotrexate Resistant Gestational Trophoblastic Neoplasia

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2018English

A Rare Cause for Gestational Trophoblastic Neoplasia: Placental Site Trophoblastic Tumor

Open Journal of Obstetrics and Gynecology
2013English

Distinct Gestational Trophoblastic Neoplasia - Different Entities, Specific Management

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2017English

Pembrolizumab Is Effective for Drug-Resistant Gestational Trophoblastic Neoplasia

The Lancet
Medicine
2017English

OP20.01: An Independent Predictor for Methotrexate Resistance in Low-Risk Gestational Trophoblastic Neoplasia With Myometrial Invasion: A Prospective Study

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2017English

Macroscopic Hematuria as a Presentation of Gestational Trophoblastic Neoplasia in an Adolescent Woman

Health
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy